Trial Profile
Evaluation of the efficacy of atorvastatin in the treatment of major depressive disorder.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Citalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- 22 May 2013 Recruitment complete, according to the Iranian Registry of Clinical Trials.
- 19 Oct 2012 Planned End Date (22 May 2013) added as reported by Iranian Registry of Clinical Trials.
- 09 Oct 2012 New trial record